Skip to main content

Concept encyclopediaConditions

Chronic Fatigue Syndrome

CFS, ME/CFS, fibromyalgia

11 passages
3 authors
1993–2024
Most-cited: Ray Peat

Chronic Fatigue Syndrome is a state of cellular energy deficiency that Ray Peat characterized as fundamentally similar to a seizure state in the brain or a failure state in the heart, driven by low progesterone and excess estrogen. He argued that the condition involves a hypometabolic physiology where cells become swollen, over-excitable, and de-energized, a process closely resembling hypothyroidism. This low-energy state is not merely subjective tiredness but a systemic failure of oxidative metabolism, often rooted in mitochondrial damage and the accumulation of polyunsaturated fatty acids (PUFAs) that inhibit the crucial respiratory enzyme cytochrome oxidase and interfere with thyroid hormone function at every level.

The etiology of the syndrome, in Peat's framework, is multifactorial but consistently points to a self-perpetuating cycle of intestinal inflammation, hormonal imbalance, and metabolic suppression. He identified dietary legumes as a common trigger, noting that the bean toxin phytohaemagglutinin acts as a powerful anti-thyroid agent, causing hepatic necrosis and suppressing mitochondrial respiration, which leads to decreased aerobic capacity. This gut-derived stress increases the absorption of endotoxin and allergens, especially during adrenergic stimulation from exertion or low blood sugar, which then promotes the release of histamine and other inflammatory substances. The resulting biochemical profile typically includes elevated nitric oxide, endorphins, serotonin, and prolactin, alongside a deficiency of vitamin D and calcium, all superimposed on an increased ratio of estrogen to progesterone and androgens.

Peat and subsequent commentators have placed significant emphasis on the role of serotonin as a direct mediator of the fatigue experience. Peat noted that excessive serotonin, often resulting from stress-induced muscle catabolism and tryptophan release, interferes with muscle mitochondria and is a major factor in related syndromes like fibromyalgia. Georgi Dinkov has extended this by highlighting the "central fatigue hypothesis," which posits that elevated brain serotonin creates a perception of severe fatigue even in the absence of peripheral biochemical markers like lactate buildup, explaining why CFS is often dismissed as hypochondria. Dinkov also noted that SSRI drugs, commonly prescribed for CFS, are paradoxically one of the worst treatments because they increase extracellular serotonin, and that viral infections implicated in CFS onset often require activation of specific serotonin receptors to take hold.

Therapeutic interventions center on restoring oxidative energy production and reducing the toxic burden. Peat advocated for strict avoidance of dietary triggers like beans and carrageenan, correction of thyroid function, and the use of anti-lipid-peroxidation agents such as vitamin E and short-chain saturated fats to counteract the effects of stored toxic PUFAs. He found that low-dose naloxone or naltrexone could break a depressed, fatigued state by suppressing the endorphins induced by lactic acid. Dinkov has further specified that restoring mitochondrial integrity involves increasing and re-saturating cardiolipin, a process achievable through thyroid hormone (T3), fully hydrogenated fats, phosphatidylcholine, and taurine, noting that CFS patients sometimes produce antibodies against their own cardiolipin. The use of antibiotics or charcoal to reduce intestinal endotoxin was also cited as a historically effective but suppressed strategy for breaking the inflammatory cycle.

People also ask

Related concepts